期刊文献+

血纤维蛋白原 胱抑素 C在急诊胸痛的临床意义 被引量:1

Clinical value of plasma fibrinogen and serum cystatin C in acute chest pain
下载PDF
导出
摘要 目的探讨急诊胸痛患者血浆纤维蛋白原(fibrinogen,Fg)、血清胱抑素C(cystatin C,Cys C)水平及其对急诊胸痛患者诊断、预后的意义。方法检测对象为2010—01—2011—01我院急诊科接诊的急诊胸痛患者484例,其中不稳定型心绞痛(unstable angina pectoris,UAP)组253例,急性心肌梗死(acute myocardial infarction,AMI)组126例;非急性冠脉综合征(acute coronary syndrome,ACS)105例为对照组。用Clauss法测定血浆Fg浓度,免疫比浊法测定血清CysC浓度。结果UAP组和AMI组的血浆Fg均高于对照组(P〈0.05),UAP组血清Cys C较对照组高(P〈0.05),但AMI组血清Cys C与对照组比较差异无统计学意义(P〉0.05);而UAP组与AMI组血清Cys C比较差异有统计学意义(P〈0.05)。结论血Fg、Cys C水平的升高可能对急诊胸痛患者的诊断有一定的价值,有助于判别ACS的存在和预后。 Objective To study the diagnostic and prognostic values of plasma fibrinogen(Fg) and serum cystatin C ( Cys C) of patients with acute chest pain. Methods We collected 484 cases with acute chest pain from January 2010 to January 2011. Unstable angina pectoris (UAP) group had 253 cases, acute myocardial infarction (AMI) group had 126 cases, and there were 105 cases with acute coronary syndrome (ACS) as control group. The Clauss method was used to detect the plasma Fg level, and the serum Cys C was measured by immunoturbidimetry. Results The level of plasma Fg and serum Cys C in UAP group and the level of plasma Fg in AMI group were higher than those in control group (P 〈 O. 05 ), but there was no difference in the level of Cys C between AMI group and control group (P 〉 0. 05). And there was statistical difference in the level of blood Fg and Cys C between UAP group and AMI group(P 〈 0.05). Conclusion The level of blood Fg and Cys C can help the diagnosis and prognosis of ACS.
出处 《中国急救医学》 CAS CSCD 北大核心 2012年第9期797-799,共3页 Chinese Journal of Critical Care Medicine
基金 基金项目:开封市科技发展计划攻关项目(110327)
关键词 急诊胸痛 急性冠脉综合征(ACS) 血浆纤维蛋白原(Fg) 血清胱抑素C(Cys C) Acute chest pain Acute coronary syndrome Plasma fibrinogen Serum cystatin C
  • 相关文献

参考文献3

二级参考文献33

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2陈灏珠.冠状动脉硬化性心脏病[M]//钟南山.内科学.第7版.北京:人民卫生出版社,2008:274-299.
  • 3Barka T,van der Noen H.Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart:use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations[J].J Histochem Cytochem,1993,41(12):1863-1867.
  • 4Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR-history,indications,and future research[J].Clin Biochem,2005,38 (1):1-8.
  • 5Derzhko R,Plaksej R,Przewlocka-Kosmala M,et al.Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction-contribution of cystatin C assessment[J].Coron Artery Dis,2009,20(7):453-461.
  • 6Kilic T,Oner G,Ural E,et al.Comparison of the long-term prognostic value of cystatin C to other indicators of renal function,markers of inflammation and systolic dysfunction among patients with acute coronary syndrome[J].Atherosclerosis,2009,207(2):552-558.
  • 7Windhausen F,Hirsch A,Fischer J,et al.Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T[J].Clin Chem,2009,55(6):1118-1125.
  • 8Kiyosue A,Hirata Y,Ando J,et al.Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ J,2010,74(11):2441-2447.
  • 9Shlipak MG,Katz R,Kestenbaum B,et al.Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J].Atherosclerosis,2009,204(1):298-303.
  • 10Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.

共引文献2166

同被引文献8

  • 1Shalia KK, Mashru MR, Shah VK, et al. Levels of cathepsins in acute myocardial infarction [ J ]. Indian Heart J, 2012,64 (3) : 290-294.
  • 2Derzhko R,Plakssei R,Przewloeka-Kosmala M,et al. Pre- diction of left ventficular dysfunction progression in patients with a first ST-elevation myocardial infarction-contribution of cystatin C assessment [ J ]. Coron Artery Dis, 2009,20 (7) : 453-461.
  • 3Pasqui AL, Di Renzo M, Bova G, et al. Pro-inflammatory/an- ti-in flammatory eytokine imbalance in acute coronary sym- dromes [ J 3. Clin Exp Med, 2006,6 ( 1 ): 38-44.
  • 4Kulach A,Dabek J,Gloogowska-Ligus J,et al. Effects of standard treatment on the dynamics of m atrix metallo- pr0teinases gene expression in patients with acute coronary syndromes [ J ]. Pharmacol Rep, 2010,62(6) : 1108-1116.
  • 5Kim EH,Yu JH,Lee SA,et al. Lack of association between serum cystatin C levels and coronary artery disease in dia- betic patients [ J ]. Korean Diabetes J, 2010,34 ( 2 ) : 95-100.
  • 6Ix JH,Shlipak MG,Chertow GM,et al. Association of cys- tatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study [ J ]. Circulation,2007,115 (2) : 173-179.
  • 7张晓红,李凯,刘凯歌.胱抑素C对急性前壁心肌梗死患者发生心功能不全的预测价值[J].山西医科大学学报,2012,43(11):839-840. 被引量:4
  • 8刘瑞杰,兰军.胱抑素C改良的GRACE风险评分对急性冠状动脉综合征患者心血管事件的预测价值[J].中国心血管杂志,2013,18(6):445-448. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部